Skip to content

The Application of Rectocele Constipation Balloon in Assisted Defecation

The Application of Rectocele Constipation Balloon in Assisted Defecation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014540
Enrollment
Unknown
Registered
2018-01-19
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectocele constipation

Interventions

Case series:Pre-defecation, vaginal built-in disposable balloon

Sponsors

Xuzhou City Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) in line with rectocele constipation in diagnostic criteria for traditional Chinese medicine constipation; (2) between 45 and 85 years of age; (3) with the treatment, can be asked in detail about the patient's history and fill in the history of the score scale. Excluding the history of intestinal or systemic organic disease, intestinal endoscopy and other auxiliary examination prompted organic disease, taking special drugs caused by constipation, breathing, digestion, circulation, blood, endocrine system serious diseases, liver and kidney function Obviously abnormal; (4) the last other treatment time and the study of treatment interval> 1 month; (5) All participants in clinical studies should agree that any food and drugs that cause a corresponding effect on gastrointestinal motility can not be used during clinical studies; (6) individuals agree to receive treatment and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) do not agree to participate in the study; (2) allergies or allergic reactions to drugs in this trial; (3) poor compliance, can not cooperate with the treatment or half-way out; (4) have severe liver and kidney dysfunction and cardiovascular, kidney, hematopoietic system, malignant tumor serious primary disease, diabetes, hyperthyroidism and other metabolic diseases and mental patients; (5) within 1 month before treatment or served during the treatment of other drugs to take defecation; (6) by colonoscopy or lower gastrointestinal examination confirmed rectum, colon organic disease (such as cancer, Crohn's disease, colon polyps, intestinal tuberculosis, etc.) caused by intestinal stenosis or abdominal surgery history; (7) combined with export obstructive constipation or irritable bowel syndrome; (8) does not meet the inclusion criteria, not in accordance with the provisions of medication, can not determine the efficacy or incomplete information, affect the efficacy or safety judgment; (9) suspected or indeed alcohol, drug abuse history. Or other factors such as the possibility of reducing the likelihood of group entry or complicating the group, such as frequent changes in the working environment, etc.; (10) Patients who are unable to obtain their full informed consent due to cognitive impairment or health status.

Design outcomes

Primary

MeasureTime frame
(visual analogue scale;(visual analogue scale;

Countries

China

Contacts

Public ContactHaihua Qian

Nanjing University of TCM

1005853094@qq.com13851949998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026